1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with physalin b in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (physalin b) | Trials (physalin b) | Recent Studies (post-2010) (physalin b) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 42 | 0 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azambuja, P; Castro, DP; Figueiredo, MB; Garcia, ES; Genta, FA; Ribeiro, IM; Tomassini, TC | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and physalin b
Article | Year |
---|---|
Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arachidonic Acid; Cell Aggregation; Enzyme Activation; Hemocytes; Insect Proteins; Phagocytosis; Platelet Activating Factor; Rhodnius; Saccharomyces cerevisiae; Secosteroids | 2009 |